What is MPP Group?
MPP Group LLC is a specialized provider of drug development services, focusing on assisting clients in the pharmaceutical industry to achieve their drug discovery objectives. The company leverages a team of seasoned research scientists, including notable figures like Dr. Michael Major, recognized for developing FDA-approved generic injectables. Their comprehensive service portfolio encompasses injectable drug development, advanced analytical services, and dedicated research and development initiatives, all supported by state-of-the-art instrumentation and rigorous testing methodologies. MPP Group is committed to process optimization and the delivery of high-quality drug formulations, aiming to improve patient outcomes and enhance the quality of life.
How much funding has MPP Group raised?
MPP Group has raised a total of $320K across 2 funding rounds:
Debt
$150K
Debt
$170K
Debt (2020): $150K with participation from PPP
Debt (2021): $170K led by PPP
Key Investors in MPP Group
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for MPP Group?
With its recent large-scale, late-stage funding, MPP Group is strategically positioned for accelerated growth and expansion. This capital injection is expected to fuel further advancements in their injectable drug development pipeline and enhance their analytical capabilities. The company's focus on optimizing processes and delivering high-quality formulations suggests a trajectory towards solidifying its market presence and potentially scaling its operations to meet increasing demand within the pharmaceutical services industry. Future developments may include strategic partnerships or further R&D investments to broaden their service offerings and reinforce their competitive edge.
See full MPP Group company page
